Author

Bicheng Ye

Zhongda Hospital Southeast UniversityORCID 0009-0008-2729-3022Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:statistical model· 2 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1

Frequent Co-Authors

Pengpeng ZhangiD· 2 shared Aimin JiangiD· 1 shared Aimin JiangiD· 1 shared Anqi LiniD· 1 shared Haoxuan YingiD· 1 shared Hong Y. YangiD· 1 shared Huiying LiuiD· 1 shared Jian ZhangiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Pengpeng ZhangORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCell ProliferationPeer-reviewedMay 1, 2025

THER: Integrative Web Tool for Tumor Hypoxia Exploration and Research

Yasi Zhang, Huiying Liu, Pengpeng Zhang…·Peng Luo

THER is a web tool that integrates hypoxia-related transcriptomic data to analyze tumor hypoxia mechanisms and drug responses.

1 citation

𝕏 PostBluesky

Cancer BiologybioRxivPreprintOct 15, 2024

Bridging the Gap in Immunotherapy Prediction: The AGAE Score as a Pan Cancer Biomarker for Immune Checkpoint Inhibitor Response

Bicheng Ye, Jun Fan, Qingren Meng…·Pengpeng Zhang

The paper develops the AGAE score, a pan-cancer biomarker for predicting immune checkpoint inhibitor response, showing improved predictive power over existing biomarkers and identifying CEP55 as a key target for immunotherapy.

DOI 10.1101/2024.10.15.618438

humanbulk RNA-seq

𝕏 PostBluesky